JIPH selected for inclusion in MEDLINE Indexing

NewsGuard 100/100 Score

- JIPH the First of Elsevier's Middle East Titles to be Selected for MEDLINE Indexing

Elsevier Middle East announces that the Journal of Infection and Public Health (JIPH) has been selected for inclusion in MEDLINE, the premier bibliographic database of the U.S. National Library of Medicine (NLM). Citations for articles indexed, the indexing terms and the abstract printed in the journal are now searchable using PubMed (http://www.pubmed.gov). Indexing using the US National Library of Medicine's (NLM) advanced MeSH terminology will be retroactive from Volume 1, Issue 1 (2008) of the journal.

"This news is very gratifying and underscores the hard work and dedication of all Editorial Board members, as well as the contributions of the authors," commented Ziad A. Memish, MD, FRCPC, FACP, JIPH Editor-in-Chief. "MEDLINE recognition means that the contributions of authors submitting their work to JIPH will now be viewed and cited more widely than ever before and we anticipate that our indexed status will have a very positive impact on manuscript submissions and international readership."

"The Middle East is an increasingly important region for scholarly research," Haifa Mughrabi, Director of Elsevier Middle East said. "JIPH is the first title from our Middle East journal portfolio to achieve this goal through the hard work and dedication of the editorial board."

SOURCE Elsevier

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine